Oracle Alpha »

Immuneering Corp - Class A shares owned by Oracle Alpha

Quarter-by-quarter ownership of Immuneering Corp - Class A (IMRX) shares owned by Oracle Alpha from 13F filings

Historical chart of Oracle Alpha investment in Immuneering Corp - Class A

Tip: Access up to 7 years of quarterly data

All positions including Immuneering Corp - Class A held by Oracle Alpha consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immuneering Corp - Class A by Oracle Alpha

Quarter filed Position value Share count Share price at filing
2023-12-31 $87k 12k 7.35

More positions owned by Oracle Alpha

Intel Corporation (INTC)
NVIDIA Corporation (NVDA)
Gitlab (GTLB)
Samsara (IOT)
Eli Lilly & Co. (LLY)
Thermo Fisher Scientific (TMO)
Snowflake Inc Cl A (SNOW)
Tesla Motors (TSLA)
Synchrony Financial (SYF)
Merck & Co (MRK)
Johnson & Johnson (JNJ)
Coinbase Global (COIN)
Procore Technologies (PCOR)
Brighthouse Finl (BHF)
Hess (HES)

View all positions for Oracle Alpha

Top funds holding Immuneering Corp - Class A

Cormorant Asset Management
T. Rowe Price Associates
Citadel Advisors
Vanguard Group
Goldman Sachs Group
TD Asset Management
Exchange Traded Concepts
Charles Schwab Investment Management
Bank of New York Mellon
Barclays
CI Private Wealth
Corton Capital
Bank of America Corporation
HighTower Advisors
Rhumbline Advisers

View all funds holding Immuneering Corp - Class A